Hair loss treatments discussed include finasteride, minoxidil, and dermarolling. Users advise patience, noting initial shedding is common and treatments take time to show results.
Hair loss advice: stick with treatment, get a good haircut, focus on maintenance, self-care, and accept oneself. Treatments mentioned: Minoxidil, Finasteride, RU58841.
The conversation is about someone considering using CB-03-01 for hair loss but has ordered finasteride, which they are hesitant to use. They are seeking advice on how to prepare CB-03-01 from powder form and the appropriate strength to use.
Accepting hair loss and not taking drastic measures like shaving your head if you are only mildly balding, and encouraging people to fight it with treatments such as finasteride, minoxidil, nizoral and microneedling. Additionally, it discusses the importance of being realistic when trying to restore hair and addressing the misconception that one must look a certain way in order to be attractive.
The user stopped taking finasteride due to side effects and is seeking alternative hair loss treatments; they currently use minoxidil and a caffeine shampoo. Suggestions include derma rolling to enhance minoxidil effectiveness and personal experiences of hair loss after stopping finasteride.
The user reported using Morr-F (topical finasteride and minoxidil), microneedling, castor and coconut oil, rosemary oil, and various supplements. They observed some hair regrowth, particularly fine hair on the crown and hairline, after four months of needling and three weeks of Morr-F.
A female user's six-month progress with only minoxidil and ketoconazole, including their experiences before and after using the treatments. They also discussed the differences between male and female hair loss and suggested that meds may offer more progress, though some results can be had without them.
User struggles with hair loss after 2.5 years on minoxidil and 1 year on finasteride, feeling depressed. Replies suggest accepting the situation and not focusing on baldness in public.